Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Page 1
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.
Rotz SJ, Bhatt NS, Hamilton BK, Duncan C, Aljurf M, Atsuta Y, Beebe K, Buchbinder D, Burkhard P, Carpenter PA, Chaudhri N, Elemary M, Elsawy M, Guilcher GMT, Hamad N, Karduss A, Peric Z, Purtill D, Rizzo D, Rodrigues M, Ostriz MBR, Salooja N, Schoemans H, Seber A, Sharma A, Srivastava A, Stewart SK, Baker KS, Majhail NS, Phelan R. Rotz SJ, et al. Among authors: majhail ns. Bone Marrow Transplant. 2024 Feb 27. doi: 10.1038/s41409-023-02190-2. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38413823 Review.
Parallel improvements in HCT techniques and supportive care entails more patients surviving long-term, creating further emphasis on survivorship needs. Survivors are at risk for developing late complications secondary to pre-, peri- and post-transplant exposures and other …
Parallel improvements in HCT techniques and supportive care entails more patients surviving long-term, creating further emphasis on s …
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.
Rotz SJ, Bhatt NS, Hamilton BK, Duncan C, Aljurf M, Atsuta Y, Beebe K, Buchbinder D, Burkhard P, Carpenter PA, Chaudhri N, Elemuary M, Elsawy M, Guilcher GM, Hamad N, Karduss A, Peric Z, Purtill D, Rizzo D, Rodrigues M, Ostriz MBR, Salooja N, Schoemans H, Seber A, Sharma A, Srivastava A, Stewart SK, Baker KS, Majhail NS, Phelan R. Rotz SJ, et al. Among authors: majhail ns. Transplant Cell Ther. 2024 Apr;30(4):349-385. doi: 10.1016/j.jtct.2023.12.001. Epub 2024 Feb 27. Transplant Cell Ther. 2024. PMID: 38413247 Free article. Review.
Parallel improvements in HCT techniques and supportive care entails more patients surviving long term, creating further emphasis on survivorship needs. Survivors are at risk for developing late complications secondary to pretransplantation, peritransplantation, and post-tr …
Parallel improvements in HCT techniques and supportive care entails more patients surviving long term, creating further emphasis on s …
Racial and Socioeconomic Disparities in Long-Term Outcomes in 1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis.
Blue BJ, Brazauskas R, Chen K, Patel J, Zeidan AM, Steinberg A, Ballen K, Kwok J, Rotz SJ, Perez MAD, Kelkar AH, Ganguly S, Wingard JR, Lad D, Sharma A, Badawy SM, Lazarus HM, Hashem H, Szwajcer D, Knight JM, Bhatt NS, Page K, Beattie S, Arai Y, Liu H, Arnold SD, Freytes CO, Abid MB, Beitinjaneh A, Farhadfar N, Wirk B, Winestone LE, Agrawal V, Preussler JM, Seo S, Hashmi S, Lehmann L, Wood WA, Rangarajan HG, Saber W, Majhail NS. Blue BJ, et al. Among authors: majhail ns. Transplant Cell Ther. 2023 Nov;29(11):709.e1-709.e11. doi: 10.1016/j.jtct.2023.07.013. Epub 2023 Jul 22. Transplant Cell Ther. 2023. PMID: 37482244
Whether the racial disparity in HCT outcomes persists in long-term survivors and possibly may be even exacerbated in this population, which frequently transitions back from the transplant center to their local healthcare providers, is unknown. In the current study, we comp …
Whether the racial disparity in HCT outcomes persists in long-term survivors and possibly may be even exacerbated in this population, …
Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: A Practical Review.
Strati P, Gregory T, Majhail NS, Jain N. Strati P, et al. Among authors: majhail ns. JCO Oncol Pract. 2023 Sep;19(9):706-713. doi: 10.1200/OP.22.00819. Epub 2023 Jul 5. JCO Oncol Pract. 2023. PMID: 37406255 Review.
The field continues to evolve rapidly and newer-generation constructs are being designed to enhance proliferative capacity, and achieve long-term persistence and greater efficacy with an overall lower incidence of toxicity. ...
The field continues to evolve rapidly and newer-generation constructs are being designed to enhance proliferative capacity, and achieve long …
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Chakraborty R, Yi J, Rybicki L, Preussler J, Deol A, Loren A, Savani B, Jim HSL, Cerny J, Reynolds J, Whitten J, Wingard JR, McGuirk JP, Uberti J, Khera N, Stiff P, Jaglowski SM, Hashmi S, Holtan SG, Devine S, Hahn T, Whalen VL, Saber W, Wood W, Baker KS, Syrjala K, Majhail NS. Chakraborty R, et al. Among authors: majhail ns. Transplant Cell Ther. 2023 Jun;29(6):388.e1-388.e6. doi: 10.1016/j.jtct.2023.02.011. Epub 2023 Mar 2. Transplant Cell Ther. 2023. PMID: 36870388
However, there is a paucity of data on health-related quality of life (HRQoL), distress, and health behaviors in long-term myeloma survivors who are in stable remission after autologous hematopoietic cell transplantation (AHCT). ...
However, there is a paucity of data on health-related quality of life (HRQoL), distress, and health behaviors in long-term myeloma su …
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period.
Gaffney KJ, Urban TA, Lucena M, Rybicki L, Majhail NS, Mossad SB. Gaffney KJ, et al. Among authors: majhail ns. Clin Hematol Int. 2023 Jun;5(2-3):65-70. doi: 10.1007/s44228-023-00029-7. Epub 2023 Feb 4. Clin Hematol Int. 2023. PMID: 36738438 Free PMC article.
There was no significant difference in the incidence of neutropenic fever; however, those in the TMP-SMX cohort were more likely to have microbiologically confirmed bacteremia (24.1% versus 8.8% respectively, p = 0.043). There was no significant difference in infections. No long- …
There was no significant difference in the incidence of neutropenic fever; however, those in the TMP-SMX cohort were more likely to have mic …
Adherence to long-term follow-up preventive practices in allogeneic hematopoietic cell transplantation survivors from North India.
Khaire NS, Chhabra P, Gupta DG, Jandial A, Khadwal A, Kasudhan KS, Kaundal S, Chopra M, Jain A, Prakash G, Majhail NS, Malhotra P, Lad DP. Khaire NS, et al. Among authors: majhail ns. Blood Cell Ther. 2022 Jun 10;5(3):83-86. doi: 10.31547/bct-2021-025. eCollection 2022 Aug 25. Blood Cell Ther. 2022. PMID: 36712553 Free PMC article.
INTRODUCTION: There are existing international guidelines for long-term follow-up (LTFU) care of allogeneic hematopoietic cell transplantation (allo-HCT) survivors. ...
INTRODUCTION: There are existing international guidelines for long-term follow-up (LTFU) care of allogeneic hematopoietic cell transp …
Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors.
Farhadfar N, Weaver MT, Al-Mansour Z, Yi JC, Jim HSL, Loren AW, Majhail NS, Whalen V, Uberti J, Wingard JR, Lynch Kelly D, Syrjala KL. Farhadfar N, et al. Among authors: majhail ns. Transplant Cell Ther. 2022 Sep;28(9):606.e1-606.e8. doi: 10.1016/j.jtct.2022.05.035. Epub 2022 May 31. Transplant Cell Ther. 2022. PMID: 35662590 Free PMC article. Clinical Trial.
Fecal microbiota of adolescent and young adult cancer survivors and metabolic syndrome: an exploratory study.
Rotz SJ, Sangwan N, Nagy M, Tzeng A, Jia M, Moncaliano M, Majhail NS, Eng C. Rotz SJ, et al. Among authors: majhail ns. Pediatr Hematol Oncol. 2022 Oct;39(7):629-643. doi: 10.1080/08880018.2022.2049937. Epub 2022 Mar 10. Pediatr Hematol Oncol. 2022. PMID: 35271405 Free PMC article.
Metabolic syndrome and obesity occur commonly in long-term pediatric cancer survivors. The intestinal microbiome is associated with metabolic syndrome and obesity in the general population, and is perturbed during cancer therapy. We aimed to determine if long-term s …
Metabolic syndrome and obesity occur commonly in long-term pediatric cancer survivors. The intestinal microbiome is associated with m …
62 results